The analysis of urological morbidity in HIV-infected patients of the Vladivostok City District

Introduction: HIV infection, the disease that develops as a result of infection with the human immunodeficiency virus, has moved from the category of fatal diseases to indolent manageable infections. Urologic diseases are a common complication observed already in the early stages of HIV infection, and the prevalence of kidney disease in these patients ranges from 5% to 30%. Our objective was to analyze urological morbidity in HIV-infected patients hospitalized for emergency and planned indications and to identify the main nosological forms of urological pathology in this population. Methods: For the analysis of epidemiological, immunological and virological characteristics of 91 HIV-infected patients admitted to the Urology Department from June 2016 to December 2019 we reviewed inpatient and outpatient medical histories, structured HIV-infected patients by urological nosologies, assessed stages of HIV infection and values of viral load and CD4+ T-lymphocytes, and established the presence of coinfections. Results: The total of 53 men (58.2%) and 38 women (41.8%) were hospitalized, their average age being 38.2 (± 9.0) years. The analysis revealed the prevalence of acute infectious and inflammatory diseases of the urinary system (pyelonephritis, prostatitis, orchiepidymitis, kidney abscess) and urolithiasis (27.5%), which in some cases required the immediate initiation of empirical antibiotic therapy and emergency drainage of the renal cavity system. Our findings are consistent with the results of studies previously conducted on a different population of HIV-infected patients. Conclusions: Since the Urology Department of Vladivostok Clinical Hospital No. 2 is the main hospital that provides both emergency and planned urology care, our data fully reflect urological morbidity of HIV-infected patients in the city district and can be used for optimization of medical care for this cohort of patients.

ВИЧ-инфекция, простатит, пиелонефрит, орхоэпидидимит, мочекаменная болезнь, HIV infection, prostatitis, pyelonephritis, orchiepididymitis, urolithiasis

1. Карамов Е.В., Ярославцева Н.Г., Щелканов М.Ю. и др. Антигенные и генетические отношения между разными подтипами ВИЧ-1 в России. Иммунология и инфекционные болезни. 1996. Т. 6. С. 15-24.

2. Покровский В.И., Покровский В.В., Юрин О.Г. Клиническая классификация ВИЧ-инфекции. Эпидемиология и инфекционные болезни. 2001. № 1. С. 7-10.

3. Максимов В., Яровой С. Урологические заболевания на фоне ВИЧ-инфекции - важная медико-социальная проблема. Врач. 2010. № 12. С. 57-60.

4. Яровой С.К. Заболевания органов мочеполовой системы на фоне ВИЧ-инфекции - новая проблема современной урологии. Исследования и практика в медицине. 2015. Т. 2, № 4. С. 115-122.

5. Маркин В.А. Оценка минимальных инфицирующих доз ВИЧ при распространении инфекции. Вопросы вирусологии. 2012. Т. 57, № 1. С. 4-8

6. Gutiérrez F. HIV/AIDS infection: the beginning of the end for today's greatest pandemic? Rev Clin Esp. 2017; 217(8):468-472. DOI: https://doi.org/10.1016/].rce.2017.04.004

7. Swanepoel C.R., Atta M.G., D'Agati V.D., et al. Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2018; 93(3):545-559. DOI: https://doi.org/10.1016/j.kint.2017.11.007

8. Beyrer С., Wirtz A.L., O'Hara G., et al. The expanding epidemic of HIV-1 in the Russian Federation. PLoS Med. 2017; 14(11):e1002462. DOI: https://doi.org/10.1371/journal.pmed.1002462

9. Heyns C.F., Smit S.G., Van der Merwe A., et al. Urological aspects of HIV and AIDS. Nat Rev Urol. 2013; 10(12):713-722. DOI: https://doi.org/10.1038/nrurol.2013.230 Cmcmöm получена: 06.07.2020 Принята в печать: 03.08.2020 Опубликована 31.08.2020 ±

10. Prakash J., Ganiger V., Prakash S., et al. Kidney disease in human immunodeficiency virus-seropositive patients: absence of human immunodeficiency virus-associated nephropathy was a characteristic feature. Indian J Nephrol. 2017; 27(4):271-276. DOI: https://doi.org/10.4103/0971-4065.202400

11. Skrzat-Klapaczynska A., Matlosz B., Bednarska A., et al. Factors associated with urinary tract infections among HIV-1 infected patients. PLoS One. 2018; 13(1):e0190564. DOI: https://doi.org/10.1371/journal.pone.0190564

12. Heron J.E., Bagnis C.I., Gracey D.M. Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV. AIDS Res Ther. 2020; 17(1):11. DOI: https://doi.org/10.1186/s12981-020-00266-3

13. Wyatt C.M. Kidney disease and HIV infection. Top Antivir Med. 2017; 25(1):13-16.

14. Jotwani V., Atta M.G., Estrella M.M. Kidney disease in HIV: moving beyond HIV-associated nephropathy. J Am Soc Nephrol. 2017; 28(11):3142-3154. DOI: https://doi.org/10.1681/ASN.2017040468

15. Palau L., Menez S., Rodriguez-Sanchez J., et al. HIV-associated nephropathy: links, risks and management. HIVAIDS (Auckl). 2018; 10:73-81. DOI: https://doi.org/10.2147/HIV.S141978

16. Reghine É.L., Foresto R.D., Kirsztajn G.M. HIV-related nephropathy: new aspects of an old paradigm. Rev Assoc Med Bras. 2020; 66(Suppl 1):s75-s81. DOI: https://doi.org/10.1590/1806-9282.66.s1.75

17. Izzedine H., Lescure F.X., Bonnet F. HIV medication-based urolithiasis. Clin Kidney J. 2014; 7(2):121-126. DOI: https://doi.org/10.1093/ckj/sfu008

18. Baladakis J., Perera M., Bolton D., et al. Is there an optimal curative option in HIV-positive men with localized prostate cancer? A systematic review. Curr Urol. 2019; 12(4):169-176. DOI: https://doi.org/10.1159/000499309

19. Coghill A.E., Engels E.A., Schymura M.J., et al. Risk of breast, prostate, and colorectal cancer diagnoses among HIV-infected individuals in the United States. J Natl Cancer Inst. 2018; 110(9):959-966. DOI: https://doi.org/10.1093/jnci/djy010

20. Coghill A.E., Suneja G., Rositch A.F., et al. HIV infection, cancer treatment regimens, and cancer outcomes among elderly adults in the United States. JAMA Oncol. 2019; 5(9):e191742. DOI: https://doi.org/10.1001/jamaoncol.2019.1742

21. Olapade-Olaopa E.O., Salami M.A., Lawal T.A. Male circumcision and global HIV/AIDS epidemic challenges. Afr J Urol. 2019; 25:3. DOI: https://doi.org/10.1186/s12301-019-0005-2